Organ differences in the enhancing potential of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine on carcinogenicity in the prostate, colon and pancreas.
暂无分享,去创建一个
K. Imaida | T. Shirai | M. Futakuchi | M. Asamoto | S. Takahashi | S. Suzuki | K. Kato
[1] K. Imaida,et al. Chemoprevention of 2-amino-1-methyl-6-phenylimidazo- [4,5-b]pyridine-induced colon carcinogenesis by 1-O-hexyl-2,3,5-trimethylhydroquinone after initiation with 1,2-dimethylhydrazine in F344 rats. , 2002, Carcinogenesis.
[2] K. Imaida,et al. Organ dependent enhancement of rat 3,2'-dimethyl-4-aminobiphenyl (DMAB) carcinogenesis by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP): positive effects on the intestine but not the prostate. , 2001, Carcinogenesis.
[3] R C Garner,et al. Analysis of DNA adducts by accelerator mass spectrometry in human breast tissue after administration of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and benzo[a]pyrene. , 2000, Mutation research.
[4] B. Magnuson,et al. Increased susceptibility of adult rats to azoxymethane-induced aberrant crypt foci. , 2000, Cancer letters.
[5] M Kulldorff,et al. 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, a carcinogen in high-temperature-cooked meat, and breast cancer risk. , 2000, Journal of the National Cancer Institute.
[6] M. Inoue,et al. More Frequent β‐Catenin Gene Mutations in Adenomas than in Aberrant Crypt Foci or Adenocarcinomas in the Large Intestines of 2‐Amino‐1‐methyl‐6‐phenylimidazo[4,5‐b]pyridine (PhIP)‐treated Rats , 2000, Japanese journal of cancer research : Gann.
[7] Satoru Takahashi,et al. Immunohistochemical Detection of Carcinogen‐DNA Adducts in Normal Human Prostate Tissues Transplanted into the Subcutis of Athymic Nude Mice: Results with 2‐Amino‐1‐methyl‐6‐phenylimidazo[4,5‐b]pyridine (PhIP) and 3,2′‐Dimethyl‐4‐aminobiphenyl (DMAB) and Relation to Cytochrome P450s and N‐Acetyltran , 2000, Japanese journal of cancer research : Gann.
[8] T. Shirai,et al. Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) in the rat prostate and induction of invasive carcinomas by subsequent treatment with testosterone propionate. , 1999, Cancer letters.
[9] K. Turteltaub,et al. DNA and protein adduct formation in the colon and blood of humans after exposure to a dietary-relevant dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[10] S. Schwartz,et al. Incidence of adenocarcinoma of the prostate in Asian immigrants to the United States and their descendants. , 1999, The Journal of urology.
[11] T. Shirai,et al. Use of polyclonal antibodies against carcinogen-DNA adducts in analysis of carcinogenesis. , 1998, Toxicology letters.
[12] M. Hirose,et al. Immunohistochemical demonstration of carcinogen-DNA adducts in tissues of rats given 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP): detection in paraffin-embedded sections and tissue distribution. , 1998, Cancer research.
[13] T. Sugimura,et al. High frequency of beta-catenin (ctnnb1) mutations in the colon tumors induced by two heterocyclic amines in the F344 rat. , 1998, Cancer research.
[14] H. Esumi,et al. Modification by 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) of 3,2'-dimethyl-4-aminobiphenyl (DMAB)-induced rat pancreatic and intestinal tumorigenesis. , 1998, Cancer letters.
[15] K. Imaida,et al. Medium-term Rat Liver Bioassay for Rapid Detection of Hepatocarcinogenic Substances , 1997 .
[16] N Ito,et al. The prostate: a target for carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) derived from cooked foods. , 1997, Cancer research.
[17] Ryohei Hasegawa,et al. Dose‐dependent Induction of Mammary Carcinomas in Female Sprague‐Dawley Rats with 2‐Amino‐l‐methyl‐6‐phenylimidazo[4,5‐b]pyridine , 1996, Japanese journal of cancer research : Gann.
[18] T. Shirai,et al. DNA adducts in target and nontarget tissues of 3,2'-dimethyl-4-aminobiphenyl in rats. , 1994, Environmental health perspectives.
[19] N Ito,et al. Dose-dependence of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine (PhIP) carcinogenicity in rats. , 1993, Carcinogenesis.
[20] L B Fay,et al. Heterocyclic aromatic amine formation in grilled bacon, beef and fish and in grill scrapings. , 1993, Carcinogenesis.
[21] T. Sugimura,et al. Exposure to heterocyclic amines. , 1993, Environmental health perspectives.
[22] N Ito,et al. A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). , 1991, Carcinogenesis.
[23] T. Sugimura,et al. Presence of carcinogenic heterocyclic amines in urine of healthy volunteers eating normal diet, but not of inpatients receiving parenteral alimentation. , 1991, Carcinogenesis.
[24] S. Fukushima,et al. Selective induction of rat urinary bladder tumors by simultaneous administration of 3,2'-dimethyl-4-aminobiphenyl (DMAB) and butylated hydroxyanisole or butylated hydroxytoluene is associated with increased DMAB-DNA adduct formation. , 1991, Carcinogenesis.
[25] T. Sugimura,et al. Heterocyclic amines: new mutagens and carcinogens in cooked foods. , 1991, Advances in experimental medicine and biology.
[26] S. Fukushima,et al. Immunohistochemical demonstration of carcinogen-DNA adducts in target and non-target tissues of rats given a prostate carcinogen, 3,2'-dimethyl-4-aminobiphenyl. , 1990, Carcinogenesis.
[27] S. Fukushima,et al. Variation in tumor yield in the prostate and other target organs of the rat in response to varied dosage and duration of administration of 3,2'-dimethyl-4-aminobiphenyl. , 1988, Cancer research.
[28] F. Hatch,et al. The isolation and identification of a new mutagen from fried ground beef: 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). , 1986, Carcinogenesis.
[29] S. Fukushima,et al. Rat prostate as one of the target organs for 3,2'-dimethyl-4-aminobiphenyl-induced carcinogenesis: effects of dietary ethinyl estradiol and methyltestosterone. , 1985, Japanese journal of cancer research : Gann.
[30] E. Longstaff,et al. Initiation/promotion versus complete carcinogenicity in the rodent liver , 1983, Environmental health perspectives.
[31] R. Möhlmann,et al. Proliferation-stimulating effect of phenacetin on the urothelium and papillary epithelium of rats. , 1983, Urologia internationalis.
[32] E. Kunze,et al. Absence of a complete carcinogenic effect of phenacetin on the quiescent and proliferating urothelium stimulated by partial cystectomy. A 2-year feeding study in rats. , 1983, Urologia internationalis.
[33] H. Zerban,et al. Biological markers of preneoplastic foci and neoplastic nodules in rodent liver * , 1982, Toxicologic pathology.
[34] K. Imaida,et al. Sequential observation of pathomorphologic alterations in preneoplastic lesions during the promoting stage of hepatocarcinogenesis and the development of short-term test system for hepatopromoters and hepatocarcinogens , 1982, Toxicologic pathology.
[35] I. Berenblum,et al. The Role of Croton Oil Applications, Associated with a Single Painting of a Carcinogen, in Tumour Induction of the Mouse's Skin , 1947, British Journal of Cancer.